Siirry suoraan sisältöön
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Tallenna

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

In Chapter 1, the CMC regulatory process is explained, the breadth of products included under the umbrella ofbiopharmaceuticals are identified, and the track record for the pharmaceutical and biopharmaceutical industry in meeting CMC regulatory compliance is discussed.
Kirjailija
John Geigert
Painos
Softcover reprint of the original 1st ed. 2004
ISBN
9781461348047
Kieli
englanti
Paino
310 grammaa
Julkaisupäivä
25.9.2012
Sivumäärä
350